Novo Nordisk
NVO
#110
Rank
S$232.56 B
Marketcap
S$52.76
Share price
0.96%
Change (1 day)
-17.60%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): S$3.85

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is S$5.07. In 2022 the company made an earnings per share (EPS) of S$2.79 an increase over its 2021 EPS that were of S$2.56.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$3.8538.05%
2022S$2.799.01%
2021S$2.5615.08%
2020S$2.2214.83%
2019S$1.93-1.68%
2018S$1.974.96%
2017S$1.8731.08%
2016S$1.43-10.33%
2015S$1.5913.91%
2014S$1.404.03%
2013S$1.35-28.81%
2012S$1.89108.9%
2011S$0.9025.59%
2010S$0.7235.01%
2009S$0.53-9.17%
2008S$0.5961.35%
2007S$0.3628.96%
2006S$0.2825.63%
2005S$0.224.17%
2004S$0.2213.55%
2003S$0.1936.87%
2002S$0.14-6.99%
2001S$0.1521.56%
2000S$0.1249.45%
1999S$0.082163.78%
1998S$0.0791712.15%
1997S$0.0705924.74%
1996S$0.05659

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.91-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.66 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.54-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$5.80 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA